We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Approves Vericiguat for Use in Patients With Heart Failure

News   Jan 26, 2021 | Original story from the University of Alberta

 
FDA Approves Vericiguat for Use in Patients With Heart Failure

Credit: rud0070/ Pixabay

 
 
Advertisement
 

RELATED ARTICLES

SARM1: A Potential Drug Target for Parkinson's and Alzheimer's Disease

News

Researchers have isolated and analyzed the structure and function of a protein called SARM1, found in the brain's nerve fibres. The protein was activated when nerve fibres were damaged by injury, disease, or as a side effect of certain drugs, suggesting it could hold potential as a therapeutic target.

READ MORE

Drug Shown To Help Diabetes Patients Lose Weight in Clinical Study

News

In a multicenter Phase 3 clinical study, the drug semaglutide was shown to help patients with diabetes lose on average 10 to 17% of their body weight.

READ MORE

Team Discovers Drug Candidates That Can Stop SARS-CoV-2 Replication

News

Two families of active substances have been discovered that can block the replication of SARS-CoV-2, by "switching off" its main protease.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE